Particle Therapy Market Report to 2023 - Global Forecast, Trends, Opportunity and Industry Analysis
Particle therapy research has following details, In secondary research process, various secondary sources like annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold
(EMAILWIRE.COM, December 12, 2018 ) Study involved four major activities to estimate current particle therapy market size for particle therapy. Exhaustive secondary research was done to collect information on market & its different subsegments. Next step was to validate these findings, assumptions, & sizing with industry experts across value chain through primary research.
Click Here for Free Sample Papers of Particle Therapy Market spread across 138 Pages, Profiling 10 Companies and Supported with 80 Tables and 36 Figures is now available at https://www.reportsnreports.com/contacts/requestsample.aspx?name=873257 .
The particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at 9.3% CAGR. Growth of this market is largely driven by factors like various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, & increasing number of particle therapy centers worldwide.
Asia Pacific is one of major revenue generating regions in particle therapy market. China and Japan are major countries responsible for high growth of this regional market owing to factors like increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries.
Get 15% Discount Now on Particle Therapy Market Research Report Now at https://www.reportsnreports.com/contacts/discount.aspx?name=873257 .
The particle therapy market has been segmented into treatment and research applications. The research applications segment is estimated to grow at the highest rate during the forecast period due to factors such as the growing awareness about the research applications of particle therapy systems, development of cost-effective and technologically advanced diagnostic and therapeutic particle therapy systems, and the increasing industry-academia collaborations in the field of research.
Premium Insights
1 Particle Therapy: Market Overview
2 Regional Analysis: Particle Therapy Market, By Product & Service
3 Particle Therapy Market Size, By Type
4 Particle Therapy Market Size, By Cancer Type
5 Regional Analysis: Particle Therapy Market, By Application
6 Particle Therapy Market, By Region
The major players in the market include Ion Beam Applications SA (Belgium), Varian Medical Systems, Inc. (US), Hitachi, Ltd. (Japan), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), ProTom International, Inc. (US), Advanced Onco therapy Plc. (UK), and Danfysik A/S (Denmark).
More Information on “Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) - Forecast to 2023” report at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=873257 .
Report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in market and provides details of competitive landscape for market leaders. Furthermore, report analyzes micro markets with respect to their individual growth trends and forecasts revenue of market segments with respect to four main regions (and the respective countries in these regions).
Breakdown of supply-side primary interviews:
• By Company Type: Tier 1–25%, Tier 2–30%, and Tier 3–45%
• By Designation:C-level–26%, Director-level–30%, and Others–44%
• By Region: North America–35%, Europe–26%, APAC–23%, and RoW–16%
Click Here for Free Sample Papers of Particle Therapy Market spread across 138 Pages, Profiling 10 Companies and Supported with 80 Tables and 36 Figures is now available at https://www.reportsnreports.com/contacts/requestsample.aspx?name=873257 .
The particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at 9.3% CAGR. Growth of this market is largely driven by factors like various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, & increasing number of particle therapy centers worldwide.
Asia Pacific is one of major revenue generating regions in particle therapy market. China and Japan are major countries responsible for high growth of this regional market owing to factors like increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries.
Get 15% Discount Now on Particle Therapy Market Research Report Now at https://www.reportsnreports.com/contacts/discount.aspx?name=873257 .
The particle therapy market has been segmented into treatment and research applications. The research applications segment is estimated to grow at the highest rate during the forecast period due to factors such as the growing awareness about the research applications of particle therapy systems, development of cost-effective and technologically advanced diagnostic and therapeutic particle therapy systems, and the increasing industry-academia collaborations in the field of research.
Premium Insights
1 Particle Therapy: Market Overview
2 Regional Analysis: Particle Therapy Market, By Product & Service
3 Particle Therapy Market Size, By Type
4 Particle Therapy Market Size, By Cancer Type
5 Regional Analysis: Particle Therapy Market, By Application
6 Particle Therapy Market, By Region
The major players in the market include Ion Beam Applications SA (Belgium), Varian Medical Systems, Inc. (US), Hitachi, Ltd. (Japan), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), ProTom International, Inc. (US), Advanced Onco therapy Plc. (UK), and Danfysik A/S (Denmark).
More Information on “Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) - Forecast to 2023” report at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=873257 .
Report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in market and provides details of competitive landscape for market leaders. Furthermore, report analyzes micro markets with respect to their individual growth trends and forecasts revenue of market segments with respect to four main regions (and the respective countries in these regions).
Breakdown of supply-side primary interviews:
• By Company Type: Tier 1–25%, Tier 2–30%, and Tier 3–45%
• By Designation:C-level–26%, Director-level–30%, and Others–44%
• By Region: North America–35%, Europe–26%, APAC–23%, and RoW–16%
Contact Information:
ReportsnReports
Mr. Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Mr. Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results